Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/large-scale-clinical-study-shows-cu-medicine-sim01-microbiome-formula-reduces-risk-of-infections-including-covid-19
https://www.med.cuhk.edu.hk/press-releases/large-scale-clinical-study-shows-cu-medicine-sim01-microbiome-formula-reduces-risk-of-infections-including-covid-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

A randomised, double-blind controlled study conducted by The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) showed that SIM01, a CUHK-developed microbiome formula, successfully reduced adverse events in high-risk individuals such as elderly subjects and diabetics following COVID-19 vaccines. The research team also found that SIM01 lowered risk of bacterial and viral infections including COVID-19. Shotgun metagenomic sequencing of stool samples confirmed that SIM01 restored a healthy gut microbiota by increasing beneficial bacteria and reducing harmful bacteria in the gut.

 

Research team from CU Medicine

A randomised, double-blind controlled study conducted by CU Medicine showed that SIM01, a CUHK-developed microbiome formula, lowered risk of bacterial and viral infections including COVID-19. The research team also found that SIM01 successfully reduced adverse events in high-risk individuals such as elderly subjects, young persons and diabetics following COVID-19 vaccines. Shotgun metagenomic sequencing of stool samples confirmed that SIM01 restored a healthy gut microbiota by increasing beneficial bacteria and reducing harmful bacteria in the gut.

(From left) Professor Francis Chan, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research; Professor Zhang Lin, Assistant Professor at CU Medicine’s Department of Medicine and Therapeutics; Professor Siew Ng, Professor of CU Medicine’s Department of Medicine and Therapeutics and Director of Microbiota I-Center (MagIC); and Professor Martin Wong of The Jockey Club School of Public Health and Primary Care at CU Medicine.

SIM01 microbiome formula restores healthy gut microbiota

 

CU Medicine previously showed that gut dysbiosis was associated with severity of COVID-19 and its complications. SIM01 was effective in hasten recovery, enhance antibody response and reducing post-vaccination inflammatory markers. In the current study, 453 subjects who had received their first dose of COVID vaccine were recruited between 2021 and 2022 and randomly assigned to receive either SIM01 or a placebo containing vitamin C for three months (control group).

 

Prof Francis Chan

Professor Francis Chan states that the large-scale, double-blind clinical study conducted by CU Medicine is the first of its kind to combine clinical and laboratory analysis, further demonstrating Hong Kong's strong medical research capability to translate scientific findings into innovations that benefit the society.

“A rigorous, randomised, double-blind, placebo-controlled clinical trial and next generation shotgun sequencing technology were used to evaluate the effectiveness of the microbiome formula in restoring a healthy gut microbiota and boost immunity against bacterial and viral infections," said Professor Zhang Lin, Assistant Professor at CU Medicine’s Department of Medicine and Therapeutics.

 

SIM01 reduces adverse events of COVID vaccines and improves health quality

 

Adverse events one month after receiving the second dose of COVID vaccine was significantly lower in the SIM01 than control groups (2.9% vs 12.6%). Regardless of vaccine type, subjects who received SIM01 also had lower rates of adverse events at 3 months (0% vs. 3.1%), 6 months (6.2% vs. 16.9%) and 12 months (5.4% vs. 17.8%) than the control group. The study also found that the SIM01 group had better sleep quality (41.4% vs. 19.3%), more positive mood (21.1% vs. 11.4%) and improved skin quality (14.1% vs. 7.0%) than the control group.

 

SIM01 reduces the risk of COVID-19 and other infections

 

An important finding was that subjects receiving SIM01 had a significantly lower risk of new COVID-19 and other bacterial and viral infections (including dermatitis, sepsis, and wound infections) than the control group (Month 1: 0.5% vs. 5.6%; Month 3: 0% vs. 0.6%; Month 6: 4.8% vs. 15.5%; Month 12: 5.4% vs. 14.4%) suggesting that SIM01 can boost immunity against other infections.

 

Professor Martin Wong Chi-sang of The Jockey Club School of Public Health and Primary Care at CU Medicine, said, "Many elderly, paediatric and chronically ill patients remain worried about possible side effects of COVID vaccine. How to effectively boost immunity in these high-risk groups against various infectious diseases during the pandemic is also a major public concern. This large clinical study has supported the effectiveness of SIM01 in reducing the risk of COVID-19 and other bacterial and viral infections.”

 

Prof. Siew Ng

Professor Siew Ng explains that a healthy gut microbiota has been associated with lower levels of inflammatory cytokines in the body and reduced risk of adverse events after vaccination. 

Restore a healthy gut microbiota to combat infection

 

The research team used next generation shotgun metagenomic sequencing to analyse stool samples from 258 people in the clinical study. The results showed a significant increase in many good bacteria and a decrease in several harmful bacteria in the gut after SIM01 suggesting that SIM01 can restore a healthy gut microbiota.

 

“A healthy gut microbiota has been associated with lower levels of inflammatory cytokines in the body and reduced risk of adverse events after vaccination," explained Professor Siew Ng, Professor of CU Medicine’s Department of Medicine and Therapeutics and Director of Microbiota I-Center (MagIC). “We have demonstrated for the first time that SIM01 can restore gut microbiota to boost immunity which is particularly important for children, elderly subjects and those with chronic illnesses.

 

Professor Francis K.L. Chan, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research, concluded, "This large-scale, double-blind clinical study is the first of its kind to combine clinical and laboratory analysis, further demonstrating Hong Kong's strong medical research capability to translate scientific findings into innovations that benefit the society. I hope the HK government will continue to provide resources and support to transform Hong Kong as a world-leading medical and innovation hub.”

 

This study was supported by the Health Bureau’s Health and Medical Research Fund (HMRF).

 

More Press Releases

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
CUHK study advises residential care homes for the elderly to maintain current infection control practices

CUHK study advises residential care homes for the elderly to maintain current infection control practices

Research
CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

Research
CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

Research
CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

Research
CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

Research
HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

Research
CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

Research
CU Medicine study shows a higher prevalence of dry eye disease  among post-COVID-19 patients

CU Medicine study shows a higher prevalence of dry eye disease among post-COVID-19 patients

Research
CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

Health Campaign
A joint HKU-CUHK study finds that smoking  increases the risk of COVID-19

A joint HKU-CUHK study finds that smoking increases the risk of COVID-19

Research
CUHK-HKU collaborative research finds a new inflammatory activation pathway in  blood vessels after SARS-CoV-2 infection

CUHK-HKU collaborative research finds a new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

Research
CU Medicine study shows distinct gut microbial profile associated with long COVID

CU Medicine study shows distinct gut microbial profile associated with long COVID

Research
Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Research
HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

Research
HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

Research
CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

Research
CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise  Performance of COVID-19 Nucleic Acid Tests

CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise Performance of COVID-19 Nucleic Acid Tests

Research
CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children  During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

Research
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and  Identifies Faecal Bacterial Markers for Autism

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
A Global Study Led by CU Medicine and HKUMed Discovers  a Hepatitis C Virus Drug as Potent Treatment for COVID-19

A Global Study Led by CU Medicine and HKUMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.